Corebridge Financial Inc. Sells 6,650 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Corebridge Financial Inc. decreased its holdings in shares of HealthEquity, Inc. (NASDAQ:HQYFree Report) by 4.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 140,865 shares of the company’s stock after selling 6,650 shares during the quarter. Corebridge Financial Inc. owned approximately 0.16% of HealthEquity worth $13,516,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in HQY. Wealthfront Advisers LLC acquired a new position in shares of HealthEquity during the 4th quarter worth about $10,304,089,000. Wasatch Advisors LP raised its holdings in HealthEquity by 6.6% during the third quarter. Wasatch Advisors LP now owns 7,758,890 shares of the company’s stock worth $635,065,000 after acquiring an additional 483,269 shares in the last quarter. Raymond James Financial Inc. acquired a new position in HealthEquity during the fourth quarter valued at approximately $45,728,000. Geneva Capital Management LLC grew its stake in HealthEquity by 24.6% in the fourth quarter. Geneva Capital Management LLC now owns 1,048,903 shares of the company’s stock valued at $100,642,000 after purchasing an additional 206,894 shares in the last quarter. Finally, Barclays PLC increased its position in shares of HealthEquity by 209.3% during the 3rd quarter. Barclays PLC now owns 166,492 shares of the company’s stock worth $13,628,000 after purchasing an additional 112,667 shares during the last quarter. Institutional investors own 99.55% of the company’s stock.

HealthEquity Price Performance

Shares of HealthEquity stock opened at $90.19 on Wednesday. The company has a 50-day simple moving average of $104.40 and a two-hundred day simple moving average of $95.94. HealthEquity, Inc. has a twelve month low of $65.01 and a twelve month high of $115.59. The stock has a market capitalization of $7.80 billion, a price-to-earnings ratio of 82.74, a price-to-earnings-growth ratio of 1.60 and a beta of 0.62. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51.

Insider Activity at HealthEquity

In related news, Director Robert W. Selander sold 5,750 shares of the firm’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the transaction, the director now owns 78,219 shares in the company, valued at approximately $8,704,992.51. This trade represents a 6.85 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 2.20% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on HQY shares. Barrington Research reissued an “outperform” rating and issued a $112.00 target price on shares of HealthEquity in a research note on Friday, March 14th. Mizuho started coverage on shares of HealthEquity in a research report on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price objective for the company. KeyCorp lowered their price objective on shares of HealthEquity from $120.00 to $110.00 and set an “overweight” rating on the stock in a research note on Monday. Raymond James upgraded shares of HealthEquity from an “outperform” rating to a “strong-buy” rating and cut their target price for the company from $120.00 to $115.00 in a research note on Tuesday. Finally, JMP Securities lifted their price target on HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a report on Tuesday, December 10th. One research analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Buy” and a consensus target price of $113.31.

Read Our Latest Research Report on HealthEquity

HealthEquity Profile

(Free Report)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Further Reading

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQYFree Report).

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.